Acatar 005% nasal spray 15ml
APAP Night is an analgesic and antipyretic drug that combines the effects of paracetamol with the sedative and hypnotic effects of diphenhydramine.
Paracetamol at a dose of 500 mg and diphenhydramine hydrochloride at a dose of 25 mg.
auxiliary substances: pregelatinised starch, povidone, crospovidone, stearic acid, microcrystalline cellulose, sodium carboxymethyl starch, magnesium stearate, maize starch, alumina blue; the tablet shell includes: Opadry blue YS-1-10524, Opadry Clear YS-1-7006.
Adults and children over 12 years: 1-2 tablets for 30 min. at bedtime.
pain, makes it easier to fall asleep and prevents night awakenings caused by pain.
Short-term pain management including: headache, osteoarticular pain, myalgia, toothache, menstrual pain, neuralgia, cold and flu related pain, causing difficulty falling asleep.< h4 style = "font-size: 18px; font-family: Lato, Helvetica, Arial, sans-serif;"> Contraindications
Do not take this medicine if: p >
- Symptoms of allergy to any component of the drug have previously been observed.
- The following conditions occur: severe liver or kidney failure, viral hepatitis, glaucoma, prostatic hyperplasia, porphyria, bronchial asthma zenia.
- During treatment with MAO inhibitors (medicines for depression) and within 2 weeks of stopping taking these medicines.
Like all medicines, APAP Night can cause side effects. These include:
- cardiac disorders: abnormal heart rate;
- blood and lymphatic system disorders: isolated cases of thrombocytopenia (low platelet counts) and agranulocytosis (very significant reduction or lack of white blood cells);
- nervous system disorders: drowsiness, dizziness;
- eye disorders: blurred vision;
- stomach and intestinal disorders: nausea, vomiting, digestive disorders, gastrointestinal disorders;
- renal and urinary disorders: renal papillary necrosis during prolonged use; urinary retention;
- general disorders and administration site conditions: dry mouth, throat and nose;
- immune system disorders: hypersensitivity reactions, i.e. urticaria, erythema, rash, pigmented purpura and anaphylactic shock (disturbance of consciousness, low urine output, hyperventilation, severe weakness);
- liver and bile duct disorders: acute liver damage occurring most commonly as a result of overdose.
Do not use the preparation simultaneously medicines containing paracetamol and diphenhydramine. In the case of concomitant use of anticoagulants (warfarin, coumarin), central nervous system depressants (such as hypnotics, sedatives and opioid analgesics), neuroleptics (used for hyperactivity), antidepressants (fluoxetine, paroxetine, antidepressants), anticonvulsants (phenytoin, carbamazepine, phenobarbital) and rifampicin (an antibiotic used to treat tuberculosis, for example) before taking the medicine, ask your doctor for advice.
Pregnancy and breast-feeding
During pregnancy and breast-feeding, contact your doctor before use. p >
Use of the drug in children and adolescents
Do not use in children under 12 years eye of life.
Driving and using machines
Do not drive or use machines while using the preparation.